Clinical trials
Phase 3 Heartburn trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 5 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 4 |
| Takeda | 4 |
| AstraZeneca | 2 |
| Eisai Inc. | 2 |
| Braintree Laboratories | 1 |
| Forest Laboratories | 1 |
| M.D. Anderson Cancer Center | 1 |
| Phathom Pharmaceuticals, Inc. | 1 |
| Southern Arizona VA Health Care System | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heartburn | 17 |
| Gastroesophageal Reflux | 8 |
| Dyspepsia | 2 |
| Digestive System Diseases | 1 |
| Esophagitis | 1 |
| Gastroparesis | 1 |
| Laryngopharyngeal Reflux | 1 |
| Nausea | 1 |
| Parasomnias | 1 |
| Sleep Initiation and Maintenance Disorders | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.